Cystic Fibrosis and the Innate Immune System: Therapeutic Implications

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 1, 2011-03 ,pp. : 8-22

Bentham Science Publishers

Access to resources Recommend Favorite

Nebulized Antibiotics in Cystic Fibrosis

By Sermetgaudelus I.  

Pediatric Drugs, Vol. 4, Iss. 7, 2002-01 ,pp. : 455-467

Adis International

Access to resources Recommend Favorite

Anti-inflammatory effects of macrolide antibiotics

By Culic O.   Erakovic V.   Parnham M.J.  

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 209-229

Elsevier

Access to resources Recommend Favorite

Disease modifying genes in cystic fibrosis: therapeutic option or one-way road?

By Büscher Rainer   Grasemann Hartmut  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Iss. 2, 2006-11 ,pp. : 65-77

Springer Publishing Company

Access to resources Recommend Favorite

Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target

By  

Current Drug Targets, Vol. 17, Iss. 13, 2016-09 ,pp. : 1535-1544

Bentham Science Publishers

Access to resources Recommend Favorite